Collaborations & Alliances
Related Searches:
Filter by:
616 - 630 of 1089 results
March 19, 2010
Syringe filters to be included with dissolution testing systems.
Read More »
March 18, 2010
PPD and Southern Research Institute have entered into a collaborative agreement for pandemic and seasonal influenza vaccine R&D in an effort to provide clients with a full spectrum of vaccine development services.
Read More »
March 17, 2010
First pact between the companies will evaluate SNALP's delivery of siRNA molecules.
Read More »
March 9, 2010
Lonza and Odyssey Thera, Inc. have signed an agreement under which Lonza will make Odyssey's Protein-fragment Complementation Assay (PCA) technology, as part of compound profiling services available to life science researchers.
Read More »
March 5, 2010
Xcellerex, Inc. and Humacyte, Inc. have entered into a strategic collaboration under which Xcellerex will develop a manufacturing process enabling the production of Humacyte’s lead regenerative drug product using its XDR single-use bioreactor system
Read More »
March 3, 2010
ADC collaboration bears fruit for Genentech with IND
Read More »
March 3, 2010
Lilly gets $1 million, keeps option to reacquire
Read More »
March 3, 2010
BMS, Allergan to co-develop Phase II-ready neuropathic pain compound
Read More »
March 2, 2010
WuXi and J&JPRD have established a preclinical services and training agreement
Read More »
February 26, 2010
Regulus Therapeutics has entered into a new collaboration with GlaxoSmithKline to develop and commercialize microRNA therapeutics targeting microRNA-122 in Hepatitis C Viral infection (HCV).
Read More »
February 23, 2010
Chiltern International and Charles River Laboratories have entered into a collaboration under which Chiltern Early Phase will partner with Charles River to conduct and support radiolabelled studies.
Read More »
February 16, 2010
AstraZeneca and Rigel Pharmaceuticals entered an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational drug for rheumatoid arthritis (RA) and additional i
Read More »
February 16, 2010
Albemarle Corp. has entered a partnership with PharmaCore to provide manufacturing capabilities for customers with projects that require high volume capacity.
Read More »
February 11, 2010
PAREXEL International and Proteome Sciences have formed an alliance focused on enhancing PAREXEL's biomarker capabilities for early phase clinical development.
Read More »
February 2, 2010
Abbott has entered an exclusive worldwide licensing agreement with Pierre Fabre SA to develop and commercialize h224G11, a preclinical monoclonal antibody targeting the cMet receptor for the potential treatment of cancer.
Read More »
616 - 630 of 1089 results
